A study into the effect of Lactobacillus casei Shirota in preventing antibiotic associated diarrhoea including Clostridioides difficile infection in patients with spinal cord injuries: a multicentre randomised, double-blind, placebo-controlled trial

A study into the effect of Lactobacillus casei Shirota in preventing antibiotic associated diarrhoea including Clostridioides difficile infection in patients with spinal cord injuries: a multicentre randomised, double-blind, placebo-controlled trial

Background: Antibiotic Associated Diarrhoea (AAD) and Clostridioides Difficile Infection (CDI) are of major concern in spinal cord injury (SCI) rehabilitation. Methods: A multi-centre, randomized, double-blind, placebo-controlled (the ECLISP) trial, was conducted in three tertiary spinal cord injury...

Full description

Bibliographic Details
Main Authors: Samford Wong, Shashivadan P Hirani, Alastair Forbes, Naveen Kumar, Ramaswamy Hariharan, Jean O'Driscoll, Anand Viswanathan, Graham Harvey, Ravi Sekhar, Ali Jamous
Format: Article
Language:English
Published: Elsevier 2021-10-01
Series:EClinicalMedicine
Subjects:
Probiotics
Spinal Cord Injury
Antibiotic Associated Diarrhoea
Malnutrition
Proton Pump Inhibitor
Clostridioides Difficile
Online Access:http://www.sciencedirect.com/science/article/pii/S2589537021003783

Internet

http://www.sciencedirect.com/science/article/pii/S2589537021003783

Similar Items